Valvular & structural heart diseaseCohort study

Temporal Trends in 1-Year Cause-Specific Mortality After Transcatheter Aortic Valve Replacement (TAVR)

JACC Cardiovasc IntervPublished

  • Retrospective registry cohort study
  • STS/ACC TVT Registry
  • competing-risk (Fine and Gray) analysis

Authors' conclusion

Noncardiac causes account for two-thirds of deaths within 1 year after TAVR.

Study context

Population
Patients who underwent isolated TAVR, Jan 2012–Oct 2022, who died within 1 year with available CoDdeaths within 1 year
Participants
36,877 patients
Outcome
Cause-specific (cardiac and noncardiac) mortality
Follow-up
1 year

Main finding

As reported in the abstract

Cause of 1-year death after TAVR
Cardiac death
11,560 (31.3%)
Noncardiac death
25,317 (68.7%)
Cardiac death, adjusted HR per year 2012–2017
0.95 (95% CI 0.92-0.97)
Noncardiac death, adjusted HR per year 2012–2017
0.92 (95% CI 0.90-0.93)
Cardiac death, adjusted HR per year 2018–2022
1.07 (95% CI 1.05-1.09)
Noncardiac death, adjusted HR per year 2018–2022
1.22 (95% CI 1.20-1.24)

Observational data: associations, not effects.

Further findings

Independent predictors of both cardiac and noncardiac death

Age >80 years, comorbidities, poor functional status, nonelective procedure, nonfemoral access, in-hospital complications

Original publication

Temporal Trends in 1-Year Cause-Specific Mortality After TAVR. JACC Cardiovasc Interv. Published 19 March 2025. doi:10.1016/j.jcin.2024.12.016

Summarised from the published abstract; every number is checked against it